Search En menu en ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages
Reference: 20160863
Release date: 26 June 2017

Promoter – Financial Intermediary

LABORATORIOS FARMACEUTICOS ROVI SA

Location

Description

The project concerns the promoter's research, development and innovation (RDI) activities for various drug-delivery technologies, including preclinical development and clinical studies.

Objectives

ROVI's pharmacological investigations involved in the project strengthen ROVI's innovativeness and help the company to maintain its competitive edge and expand its international footprint.

Sector(s)

Proposed EIB finance (Approximate amount)

EUR 45 million

Total cost (Approximate amount)

EUR 94 million

Environmental aspects

The Bank will require that projects financed under this operation comply with applicable domestic and EU legislation, as appropriate.

Procurement

The Bank will require that projects financed under this operation comply with applicable domestic and EU legislation.

Status

Signed - 21/12/2017

Disclaimer

Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

Related tags

Spain Industry